|
1
|
Meyfroidt S, Stevens J, De Lepeleire J,
Westhovens R, De Cock D, Van Der Elst K, Vanhaecht K and
Verschueren P: A general practice perspective on early rheumatoid
arthritis management: A qualitative study from Flanders. Eur J Gen
Pract. 21:231–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abram SG, Nicol F, Hullin MG and Spencer
SJ: The long-term outcome of uncemented low contact stress total
knee replacement in patients with rheumatoid arthritis: Results at
a mean of 22 years. Bone Joint J. 95-B:1–1499. 2013. View Article : Google Scholar
|
|
3
|
Avina-Zubieta JA, Abrahamowicz M, De Vera
MA, Choi HK, Sayre EC, Rahman MM, Sylvestre MP, Wynant W, Esdaile
JM and Lacaille D: Immediate and past cumulative effects of oral
glucocorticoids on the risk of acute myocardial infarction in
rheumatoid arthritis: A population-based study. Rheumatology
(Oxford). 52:68–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Halabi H, Alarfaj A, Alawneh K, Alballa S,
Alsaeid K, Badsha H, Benitha R, Bouajina E, Al Emadi S, El Garf A,
et al: Challenges and opportunities in the early diagnosis and
optimal management of rheumatoid arthritis in Africa and the Middle
East. Int J Rheum Dis. 18:268–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andersson U and Tracey KJ: HMGB1 as a
mediator of necrosis-induced inflammation and a therapeutic target
in arthritis. Rheum Dis Clin North Am. 30:627–637, xi. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Szabo-Taylor KE, Eggleton P, Turner CA,
Faro ML, Tarr JM, Tóth S, Whiteman M, Haigh RC, Littlechild JA and
Winyard PG: Lymphocytes from rheumatoid arthritis patients have
elevated levels of intracellular peroxiredoxin 2 and a greater
frequency of cells with exofacial peroxiredoxin 2, compared with
healthy human lymphocytes. Int J Biochem Cell Biol. 44:1223–1231.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calmon-Hamaty F, Combe B, Hahne M and
Morel J: Lymphotoxin alpha stimulates proliferation and
pro-inflammatory cytokine secretion of rheumatoid arthritis
synovial fibroblasts. Cytokine. 53:207–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsiao HB, Hsieh CC, Wu JB, Lin H and Lin
WC: Kinsenoside inhibits the inflammatory mediator release in a
type-II collagen induced arthritis mouse model by regulating the T
cells responses. BMC Complement Altern Med. 16:802016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pavelka K, Kavanaugh AF, Rubbert-Roth A
and Ferraccioli G: Optimizing outcomes in rheumatoid arthritis
patients with inadequate responses to disease-modifying
anti-rheumatic drugs. Rheumatology (Oxford). 51 Suppl 5:v12–v21.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan H, Yang P, Zhou D, Gao W, Qiu Z, Fang
F, Ding S and Xiao W: Knockdown of sphingosine kinase 1 inhibits
the migration and invasion of human rheumatoid arthritis
fibroblast-like synoviocytes by down-regulating the PI3K/AKT
activation and MMP-2/9 production in vitro. Mol Biol Rep.
41:5157–5165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mitra A, Raychaudhuri SK and Raychaudhuri
SP: IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR
signaling cascade. Cytokine. 60:38–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiu YC, Lin CY, Chen CP, Huang KC, Tong
KM, Tzeng CY, Lee TS, Hsu HC and Tang CH: Peptidoglycan enhances
IL-6 production in human synovial fibroblasts via TLR2 receptor,
focal adhesion kinase, Akt, and AP-1-dependent pathway. J Immunol.
183:2785–2792. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li GQ, Zhang Y, Liu D, Qian YY, Zhang H,
Guo SY, Sunagawa M, Hisamitsu T and Liu YQ: PI3 Kinase/Akt/HIF-1α
pathway is associated with hypoxia-induced epithelial-mesenchymal
transition in fibroblast-like synoviocytes of rheumatoid arthritis.
Mol Cell Biochem. 372:221–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Li W, Ye C, Lin Y, Cheang TY, Wang
M, Zhang H and Wang S, Zhang L and Wang S: Gambogic acid induces
G0/G1 cell cycle arrest and cell migration inhibition via
suppressing PDGF receptor β tyrosine phosphorylation and Rac1
activity in rat aortic smooth muscle cells. J Atheroscler Thromb.
17:901–913. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jang SW, Okada M, Sayeed I, Xiao G, Stein
D, Jin P and Ye K: Gambogic amide, a selective agonist for TrkA
receptor that possesses robust neurotrophic activity, prevents
neuronal cell death. Proc Natl Acad Sci USA. 104:16329–16334. 2007;
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu N, Yang Y, You QD, Ling Y, Gao Y, Gu
HY, Zhao L, Wang XT and Guo QL: Gambogic acid inhibits angiogenesis
through suppressing vascular endothelial growth factor-induced
tyrosine phosphorylation of KDR/Flk-1. Cancer Lett. 258:80–89.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia Z and He J: Paeoniflorin ameliorates
rheumatoid arthritis in rat models through oxidative stress,
inflammation and cyclooxygenase 2. Exp Ther Med. 11:655–659. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de la Torre I, Leandro MJ, Edwards JC and
Cambridge G: Baseline serum immunoglobulin levels in patients with
rheumatoid arthritis: Relationships with clinical parameters and
with B-cell dynamics following rituximab. Clin Exp Rheumatol.
30:554–560. 2012.PubMed/NCBI
|
|
19
|
Roberts CA, Dickinson AK and Taams LS: The
interplay between monocytes/macrophages and CD4(+) T cell subsets
in rheumatoid arthritis. Front Immunol. 6:5712015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
El-Kady IM and El-Masry SA:
Pro-inflammatory and anti-inflammatory cytokines profile in
rheumatoid arthritis patients. Egypt J Immunol. 15:109–114.
2008.PubMed/NCBI
|
|
21
|
Ferraccioli G and Gremese E:
Thrombogenicity of TNF alpha in rheumatoid arthritis defined
through biological probes: TNF alpha blockers. Autoimmun Rev.
3:261–266. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu D, Guo M, Hu Y, Liu T, Yan J, Luo Y,
Yun M, Yang M, Zhang J and Guo L: Effect of sanhuangwuji powder,
anti-rheumatic drugs, and ginger-partitioned acupoint stimulation
on the treatment of rheumatoid arthritis with peptic ulcer: A
randomized controlled study. J Tradit Chin Med. 35:273–280. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cobo-Ibáñez T, Descalzo MÁ,
Loza-Santamaría E, Carmona L and Munoz-Fernandez S: Serious
infections in patients with rheumatoid arthritis and other
immune-mediated connective tissue diseases exposed to anti-TNF or
rituximab: Data from the Spanish registry BIOBADASER 2.0. Rheumatol
Int. 34:953–961. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu Y, Zhu Q, Song J, Liu H, Miao Y, Yang
F, Wang F, Cheng W, Xi Y, Niu X, et al: Regulatory effect of
iguratimod on the balance of Th subsets and inhibition of
inflammatory cytokines in patients with rheumatoid arthritis.
Mediators Inflamm. 2015:3560402015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu T and Mohan C: The AKT axis as a
therapeutic target in autoimmune diseases. Endocr Metab Immune
Disord Drug Targets. 9:145–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oranskiy SP, Yeliseyeva LN, Tsanaeva AV
and Zaytseva NV: Body composition and serum levels of adiponectin,
vascular endothelial growth factor, and interleukin-6 in patients
with rheumatoid arthritis. Croat Med J. 53:350–356. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hetland ML, Christensen IJ, Lottenburger
T, Johansen JS, Svendsen MN, Hørslev-Petersen K, Nielsen L and
Nielsen HJ: Circulating VEGF as a biological marker in patients
with rheumatoid arthritis? Preanalytical and biological variability
in healthy persons and in patients. Dis Markers. 24:1–10. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hah YS, Koh YJ, Lim HS, Kim HO, Cheon YH,
Noh HS, Jang KY, Lee SY, Lee GM, Koh GY and Lee SI:
Double-antiangiogenic protein DAAP targeting vascular endothelial
growth factor A and angiopoietins attenuates collagen-induced
arthritis. Arthritis Res Ther. 15:R852013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li GF, Qin YH and Du PQ: Andrographolide
inhibits the migration, invasion and matrix metalloproteinase
expression of rheumatoid arthritis fibroblast-like synoviocytes via
inhibition of HIF-1α signaling. Life Sci. 136:67–72. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brouwer E, Gouw AS, Posthumus MD, van
Leeuwen MA, Boerboom AL, Bijzet J, Bos R, Limburg PC, Kallenberg CG
and Westra J: Hypoxia inducible factor-1-alpha (HIF-1alpha) is
related to both angiogenesis and inflammation in rheumatoid
arthritis. Clin Exp Rheumatol. 27:945–951. 2009.PubMed/NCBI
|
|
31
|
Seo Y, Ji YW, Lee SM, Shim J, Noh H, Yeo
A, Park C, Park MS, Chang EJ and Lee HK: Activation of HIF-1α
(hypoxia inducible factor-1α) prevents dry eye-induced acinar cell
death in the lacrimal gland. Cell Death Dis. 5:e13092014.
View Article : Google Scholar : PubMed/NCBI
|
